Phosphorylated Myosin Light Chain 2 (p-MLC2) as a Molecular Marker of Antemortem Coronary Artery Spasm

Abstract

BackgroundIt is not uncommon that only mild coronary artery stenosis is grossly revealed after a system autopsy. While coronary artery spasm (CAS) is the suspected mechanism of these deaths, no specific biomarker has been identified to suggest antemortem CAS.Material/MethodsTo evaluate the potential of using phosphorylated myosin light chain 2 (p-MLC2) as a diagnostic marker of antemortem CAS, human vascular smooth muscle cells (VSMCs) were cultured and treated with common vasoconstrictors, including prostaglandins F2α (PGF2α), acetylcholine (ACh), and 5-hydroxy tryptamine (5-HT). The p-MLC2 level was examined in the cultured cells using Western blot analysis and in a rat model of spasm provocation tests using immunohistochemistry (IHC). Effects of increased p-MLC2 level on VSMCs contractile activities were assessed in vitro using confocal immunofluorescence assay. Four fatal cases with known antemortem CAS were collected and subject to p-MLC2 detection.ResultsThe p-MLC2 was significantly increased in VSMCs after treatments with vasoconstrictors and in the spasm provocation tests. Myofilament was well-organized and densely stained in VSMCs with high p-MLC2 level, but disarrayed in VSMCs with low p-MLC2 level. Three of the 4 autopsied cases showed strongly positive staining of p-MLC2 at the stenosed coronary segment and the adjacent interstitial small arteries. The fourth case was autopsied at the 6th day after death and showed negative-to-mild positive staining of p-MLC2.Conclusionsp-MLC2 might be a useful marker for diagnosis of antemortem CAS. Autopsy should be performed as soon as possible to collect coronary arteries for detection of p-MLC2.

Mast cell function in prostate inflammation, fibrosis, and smooth muscle cell dysfunction

“…As our combination treatment interferes with the release of mast cell proteases and tryptases, we next examined the consequences of the combination treatment on smooth muscle cell contraction. We assessed smooth muscle cell contraction by assessing the phosphorylation status of myosin light chain (MLC) -2, phosphorylation and de-phosphorylation of which regulates muscle contraction and relaxation respectively (49–51), in the prostates from control, CP1-infected untreated and CrS + CeHCl treated mice. As seen in Fig.…”

Opposite effects of cannabinoid CB1 and CB2 receptors on antipsychotic clozapine‐induced cardiotoxicity

“…Total proteins were extracted from cells or tissue homogenates using RIPA containing protease inhibitor and phosphatase inhibitor cocktail (Calbiochem, EMD Biosciences, San Diego, CA, USA). The protocol used for Western blot analysis was in accordance with our previous study (Li et al, ). Briefly, protein was measured by a BCA kit (Pierce, San Francisco, CA, USA), and an equal amount of protein (40 ng) was loaded on 10% SDS‐PAGE gel and transferred onto a PVDF membrane (pore size 0.45 μm, Bio‐Rad, Hercules, CA, USA) using a semidry transfer apparatus (BioRad).…”

O-GlcNAcylation: The Underestimated Emerging Regulators of Skeletal Muscle Physiology

“…These data also show that MLC2 phosphorylation causes changes in the structure of thick filaments and increase the number of cross bridges and their attachments because calcium sensitivity is directly proportional to the ATPase activity of actomyosin [ 232 ]. It is further explained that the electrostatic repulsion between the negative charge of phosphate added on MLC and MHC causes the position of myosin head to move, thus promoting the formation of cross bridges [ 233 ]. MLC2 phosphorylation is slower than contraction in terms of kinetics, which is regarded as a biochemical memory [ 234 ].…”